TY - JOUR AU - Gupta, S. C. AU - Kismali, G. AU - Aggarwal, B. B. PY - 2013 DA - 2013// TI - Curcumin, a component of turmeric: from farm to pharmacy JO - Biofactors. VL - 39 UR - https://doi.org/10.1002/biof.1079 DO - 10.1002/biof.1079 ID - Gupta2013 ER - TY - JOUR AU - Kumaravel, M. AU - Sankar, P. AU - Latha, P. AU - Benson, C. S. AU - Rukkumani, R. PY - 2013 DA - 2013// TI - Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study with curcumin JO - Nat Prod Commun. VL - 8 ID - Kumaravel2013 ER - TY - STD TI - Avasarala S, Zhang F, Liu G, Wang R, London SD, London L, et al. Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. Plos One. 2013;8:e57285. ID - ref3 ER - TY - JOUR AU - Peng, F. AU - Tao, Q. AU - Wu, X. AU - Dou, H. AU - Spencer, S. AU - Mang, C. PY - 2012 DA - 2012// TI - Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger JO - Fitoterapia. VL - 83 UR - https://doi.org/10.1016/j.fitote.2011.12.028 DO - 10.1016/j.fitote.2011.12.028 ID - Peng2012 ER - TY - JOUR AU - Lim, K. J. AU - Bisht, S. AU - Bar, E. E. AU - Maitra, A. AU - Eberhart, C. G. PY - 2011 DA - 2011// TI - A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors JO - Cancer Biol Ther. VL - 11 UR - https://doi.org/10.4161/cbt.11.5.14410 DO - 10.4161/cbt.11.5.14410 ID - Lim2011 ER - TY - JOUR AU - Anand, P. AU - Kunnumakkara, A. B. AU - Newman, R. A. AU - Aggarwal, B. B. PY - 2007 DA - 2007// TI - Bioavailability of curcumin: problems and promises JO - Mol Pharm. VL - 4 UR - https://doi.org/10.1021/mp700113r DO - 10.1021/mp700113r ID - Anand2007 ER - TY - STD TI - Wei X-L, Han Y-R, Quan L-H, Liu C-Y, Liao Y-H. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation. Eur J Pharm Sci. 2013;49:286–93. ID - ref7 ER - TY - JOUR AU - Jain, R. A. AU - Brito, L. AU - Straub, J. A. AU - Tessier, T. AU - Bernstein, H. PY - 2008 DA - 2008// TI - Effect of powder processing on performance of fenofibrate formulations JO - Eur J Pharm Biopharm. VL - 69 UR - https://doi.org/10.1016/j.ejpb.2007.12.006 DO - 10.1016/j.ejpb.2007.12.006 ID - Jain2008 ER - TY - STD TI - Liu P, Rong X, Laru J, Veen B van, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411:215–22. ID - ref9 ER - TY - JOUR AU - Courrier, H. AU - Butz, N. AU - Vandamme, T. F. PY - 2002 DA - 2002// TI - Pulmonary drug delivery systems: recent developments and prospects JO - Crit Rev Ther Drug Carrier Syst. VL - 19 UR - https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v19.i45.40 DO - 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40 ID - Courrier2002 ER - TY - STD TI - Xu L-M, Hu T-T, Pu Y, Le Y, Chen J-F, Wang J-X, et al. Preparation of high-performance ultrafine budesonide particles for pulmonary drug delivery. Chem Eng J. 2014;252:281–7. ID - ref11 ER - TY - JOUR AU - Rohani, S. S. R. AU - Abnous, K. AU - Tafaghodi, M. PY - 2014 DA - 2014// TI - Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients JO - Int J Pharm. VL - 465 UR - https://doi.org/10.1016/j.ijpharm.2014.02.030 DO - 10.1016/j.ijpharm.2014.02.030 ID - Rohani2014 ER - TY - JOUR AU - Klingler, C. AU - Müller, B. W. AU - Steckel, H. PY - 2009 DA - 2009// TI - Insulin-micro-and nanoparticles for pulmonary delivery JO - Int J Pharm. VL - 377 UR - https://doi.org/10.1016/j.ijpharm.2009.05.008 DO - 10.1016/j.ijpharm.2009.05.008 ID - Klingler2009 ER -